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Melanophore-stimulating hormone (MSH) release from the pars intermedia of the pitui- 
tary gland is probably regulated by multiple factors of hypothalamic origin. We have exam- 
ined a number of potential reguiatory factors for their effects on MSH release from the 
amphibian Xenopus /a&s. Serotonin and acetylcholine have no effect on MSH release. 
Both adrenaline and noradrenaline inhibit release of MSH in a dose-dependent manner. 
Studies with specific receptor agonists and antagonists reveal that these neurotransmitters 
exert their in vitro effects primarily through a dopamine D-2 receptor, although an ol-adren- 
ergic receptor could not be excluded. We further conclude that the pars intermedia of X. 
laevis lacks a O-adrenergic receptor for the regulation of MSH secretion from the pars 
intermedia. In mammals, this receptor activates the adenylate cyclase system. Our studies 
reveal that despite the lack of O-adrenergic receptors, cyclic-AMP is likely an intracellular 
factor involved in the stimulation of MSH release. 0 1986 Academic PESS, IIIC. 
Melanophore-stimulating hormone 
(MSH), released from the pars intermedia 
of the pituitary gland, controls pigment dis- 
persion in dermal melanophores during 
background adaptation of amphibians. The 
release of this hormone is regulated by 
factors of hypothalamic origin which are 
thought to be released from nerves termi- 
nating in the neurointermediate lobe. Hypo- 
thalamic regulation is believed to be mainly 
inhibitory. Dopamine is thought to be a 
very important neurotransmitter in this re- 
gard (Davis and Hadley, 1978; Jenks, 1977; 
Terlou et al., 1974), and in at least one am- 
phibian species (Verburg-van Kemenade et 
aE., 1986) the neurotransmitter GABA is 
likely involved. Other classical neurotrans- 
mitters have also been implicated in the 
regulation of melanotropin release. The in- 
d&amine serotonin has been reported to 
stimulate release from melanotropes of 
lower vertebrates (Thornton and Gesch- 
wind, 1975) and a cholinergic mechanism 
has been suggested for stimulation of the 
pars intermedia of an hmphibian species 
(Hadley et al., 1976; Dierst-Davis et al., 
1966). In mammals, a P-adrenergic met 
nism for stimulation of melanotropin secre- 
tion is well established (Cote et al., 1980; 
Tilders et al., 1981). Stimulation of this p- 
receptor activates the adenylate cyclase 
system, thus increasing intracellular levels 
of cyclic-AMP (cAMP), which leads to ele- 
vated release of MSH (Cote et al., 1980; 
Munemura et al., 1980). For amphibians, 
the initial indication of P-adrenergic stimu- 
lation of MSH secretion from Rnna pipiens: 
(Bower et al., 1974) has recently been ex- 
tended to a second amphibian species, 
Rana ridibunda (Tonon et al., 1983). XII the 
aquatic toad Xenopus laevis, the p-adren 
ergic receptor’ agonist isopro’terenol has 
been reported to inhibit the release of &WI 
and other peptides derived from the 
common prohormone pro-o,piomelanoj 
cortin (Loh and Gainer, 1977). This obser- 
vation appears to be in agreement with a 
report that CAMP inhibits M!SH release in 
this species (Loh et al., 1981), although it 
has earlier been reported’that cGMP is exl 
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tremely potent in stimulating release of 
MSH from Xenopus neurointermediate 
lobes (Jenks, 1977). In addition to the B-ad- 
renergic receptor, the presence of a-adren- 
ergic receptors on melanotropes of both an 
amphibian (Bower et al., 1974) and a mam- 
malian species (Jackson and Lowry, 1983) 
has been proposed. In both cases this re- 
ceptor is reported to be involved in inhibi- 
tion of MSH release. We have undertaken a 
study to evaluate the possible involvement 
of various neurotransmitters in the control 
of MSH release from the pars intermedia of 
X. laevis. This study was accomplished 
through the analysis of release of immuno- 
reactive melanotropin from superfused 
neurointermediate lobes. By using specific 
receptor agonists and antagonists, an at- 
tempt was made to characterize the re- 
ceptor mechanisms involved. As the physi- 
ological state of the animal (i.e., white- or 
black-background-adapted) may have some 
influence on melanotrope sensitivity to se- 
cretagogues, we tested each potential se- 
cretagogue on neurointermediate lobes of 
both white- and black-background-adapted 
animals. 
MATERIALS AND METHODS 
Animals. X. laevis were bred and reared in our ac- 
quatic facility. Animals were adapted to black or white 
background in black or white containers under con- 
stant illumination at 22”. Degree of pigment dispersion 
in dermal melanophores was determined by measure- 
ment of the melanophore index according to Hogben 
and Slome (1931). 
In vitro superfusion experiments. Details con- 
cerning our method of superfusion of neurointerme- 
diate lobes are given elsewhere (Verburg-van Ke- 
menade et al., 1986). Briefly, super-fusion was per- 
formed using small perifusion chambers (10 pl), each 
containing an individual lobe. The incubation medium 
contained 112 mM NaCl, 2 mM KCl, 2 rn44 CaCl,, 15 
mM Hepes, pH 7.38, 0.3 mgiml BSA, 2 mg/ml glu- 
cose. Medium was pumped through each chamber (1.5 
ml/hr) and fractions of 7.5 min were collected. Frac- 
tions were stored frozen (- 20”) before submitting 
them to radioimmunoassay for MSH determinations. 
As described earlier (Verburg-van Kemenade et a/., 
1986), within an experiment the results of those lobes 
showing similar baseline patterns of release were 
grouped, percentage basal release was calculated for 
each lobe within the group, and these values were 
then averaged. Neurotransmitters, or their specific ag- 
onists or antagonists, were administered at various 
time periods during the superfusion. The following 
products were tested either individually or in various 
combinations: the neurotransmitters serotonin, ace- 
tylcholine, adrenaline, and noradrenaline; the cu-ad- 
renergic receptor agonist phenylephrine and its antag- 
onist phentolamine; the B-adrenergic receptor agonist 
isoproterenol and its antagonist propranolol; and the 
dopamine D-2 receptor antagonist sulpiride (all pur- 
chased from Sigma). Several experiments were con- 
ducted using the cyclic-AMP analog g-bromo-adeno- 
sine 3’,5’-monophosphate (8-Br-CAMP, Sigma). 
Radioimmunoassay. The MSH concentration in the 
effluent was quantified by radioimmunoassay, using 
an antiserum produced and characterized by Vaudry 
et al. (1978). It shows equal cross-reactivity to des- 
acetyl-cY-MSH and a-MSH. Immunobound and un- 
bound radioactive MSH were separated by precipita- 
tion with polyethylene glycol. Synthetic a-MSH 
(Sigma) was used as a standard. All samples were 
measured in duplicate. 
RESULTS 
Effects of serotonin and acetylcholine. 
Serotonin in concentrations ranging from 
10Vg to lop5 M was unable to alter basal 
MSH secretion in lobes from black- or 
white-adapted animals. Figure lb shows 
the results- from superfusion experiments 
whereby 10P8, 10e6, and lop5 M of sero- 
tonin were tested. Similarly, basal secre- 
tion was unaffected by acetylcholine in 
concentrations ranging from 10eg to 10P5 
M (Fig. la). 
Involvement of wadrenergic and p-ad- 
renergic receptor mechanisms. The two 
neurotransmitters adrenaline and noradren- 
aline exhibited a dose-dependent inhibitory 
effect on secretion of immunoassayable 
c+MSH (Fig. 2a and Table 1). Effective 
concentrations ranged from 10e7 to 10m5 M 
(Table 1). The lobes were slightly more 
sensitive to adrenaline than to noradrena- 
line. The inhibition of MSH secretion in- 
duced by adrenaline or by noradrenaline, 
both applied at a concentration of 10P6 M, 
was not affected by the ol-adrenergic re- 
ceptor antagonist phentolamine (Figs. 2c 
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FIG. 1. Effects of acetylcholine and serotonin on 
MSH secretion from superfused neurointermediate 
lobes of black-background-adapted Xenopus laevis. In 
each experiment 7.5min superfusion fractions were 
collected; secretagogues were given during three 15 
min periods at the concentrations indicated. (a) Ace- 
tylcholine results show the mean of four individual ex- 
periments where 100% basal release for each lobe was 
716, 880, 864, and 652 pg MSHifraction. (b) Serotonin 
results show the mean of two individual experiments 
where 100% basal release for each lobe was 548 and 
1160 pg MSH/fraction. Bars represent -SEM. 
and d) nor by the P-adrenergic receptor an- 
tagonist propranolol (Fig. 2b). Both antago- 
nists were tested in concentrations of up to 
10V4 M. When adrenaline was, however, 
used in concentrations of lo-’ M, we ob- 
served a partial blockage of the inhibition 
by phentolamine (Table 2). The inhibitory 
effect on secretion induced by 10V6 M 
adrenaline or 10m6 M noradrenaline could 
be blocked by the dopamine D-2 receptor 
antagonist sulpiride (Figs. 2e and f). The (Y- 
adrene,rgic agonist phenylephrine inhibited 
secretion ‘when used at high concentrations 
of 10V5 M (Table I). The, inhibition of MSH 
secretion induced by 2 x 10e5 M of phen- 
ylephrinel was to a great extent antagonized 
by the administration of 10d4 M of phentol- 
amine (Fig. 3). 
In neurointermediate lobes of black- 
adapted animals, the P-adrenergic receptor 
agonist isoproterenol appeared to be un- 
able to alter the basal level of MSH secre- 
tion when added in low concentrations of 
10-10-10-7 M. At high concentrations 
(1O-5 M), the effect of isoproterenol on 
MSH secretion is clearly inhibitory (Fig. 
4a). This inhibitory effect on melanotr 
secretion could not be blocked with pro- 
pranolol (Fig. 4~). Both sulpiride and phen- 
tolamine were, however, able to block the 
isoproterenol-induced inhibition (Fig. 4d 
and Table 2). An experiment with isopro- 
terenol, but with lobes from white-adapted 
animals, did not show any stimulatory ef- 
fect for this substance (Fig. 4b). Moreover, 
in an experiment with lobes from black- 
adapted animals that were maintained con- 
tinuously under submaximum, inhibition by 
dopamine ( 10e6 M), isoproterenol again 
failed to induce stimulation of release. 
Also, we could not demonstrate any stimu- 
lation with isoproterenol in experiments 
that were conducted with the incubdtion 
medium at pH 6.8. Hadley et al. (1976) 
have reported that in Rana, lowering the 
pH of the incubation medium reduced basal 
levels of melanotropin secretion, thus in- 
creasing sensitivity in detecting stimuiatory 
effects on secretion. In Xenopus we foun 
no reduction in basal secretion after low- 
ering the pH from 7.38 to 6.80. 
Effects ofcyclic-AMP. Lobes originating 
from animals adapted to a black back- 
ground appeared to be insensitive to 8-R- 
cyclic-AMP (Fig. 5a). Additional experi- 
ments, where 8-Br-cyclic-AMP was given 
for SO-min periods, also showed no effect 
of this substance on MSH release. In com- 
parison to lobe,s from black-adapted an- 
imals, lobes from white-adapted animals 
showed ‘considerably more variation in 
their baseline pattern of MSH release, 
which generally tended to decl 
more rapidly. FigurmSSb, c, and 
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FIG. 2. Effects of noradrenaline, adrenaline, and receptor antagonists (propranolol, S-adrenergic 
receptor antagonist; phentolamine, ol-adrenergic receptor antagonist; sulpiride, dopamine D-2 re- 
ceptor antagonist) on MSH secretion from superfused nemointermediate lobes of black-background- 
adapted Xenopus laevis. In each experiment noradrenaline or adrenaline was given during three 15 
min periods; administration of the receptor antagonist was started several fractions before the second 
pulse of noradrenaline or adrenaline and continued for several fractions after this pulse, as indicated in 
the figure. All graphs represent the mean of two to four experiments and the bars represent - SEM. 
Basal levels of release for the individual lobes within each experiment were (a) noradrenaline, 1344 
and 3060 pg MSH/fraction; (b) noradrenalineipropranolol, 770 and 1888 pg MSH/fraction; (c) nor- 
adrenalineiphentolamine, 1464, 1756, 2120, and 2948 pg MSH/fraction; (d) adrenalineiphentolamine, 
1000, 1512, and 756 pg MSH/fraction; (e) noradrenalineisulpiride, 1552,2360, 2928, and 1640 pg MSHi 
fraction; and (f) adrenalineisulpiride, 276 and 1560 pg MSHifraction. 
suits of neurointermediate lobes of white- DISCUSSION 
adapted animals, where lobes with similar Previous studies have shown that the 
baseline patterns of release were grouped physiological state of the neurointerme- 
together and averaged. Cyclic-AMP gave a diate lobe tissue remains viable during a 6-h 
dramatic increase in MSH release, but es- superfusion period (Martens et aZ., 1981; 
tablishing clear dose-response relation- Verburg-van Kemenade et al., 1986). Fol- 
ships was difficult. lowing in vitro super-fusion we have found 
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TABLE 1 
DOSE-RESPONSE RELAT~ONSHW FOR THE INHIBITION OF MSH SECRETION FROM SUPERFUSED 
NEUROIFJTERMEDIATE LOBES OF Xenopus laevis BY ADRENALINE AND NORADRENALINE AND BY THE 
ADRENERGIC RECEF~OR AGONISTS ISOPROTERENOL (B-RECEPTOR) AND PHENYLEPHRINE (WRECEPTO~) 
% Inhibition of MSH secretion 
10-g M 10-S M lo-‘M lo-6M 10-J M 
Noradrenaline 0 (2) 0 (2) 32 i 5.8 (5) x3 2 3.3 (20) loo * 0.0 (2) 
Adrenaline 0 (2) 0 (2) 68 +- 5.5 (11) 86 z!z 2.6 (19) 100 4 1.0 (5) 
Isoproterenol 0 (2) 0 (2) 0 (3) 28 r 1.4 (2) 66 2 4.4 (23) 
Phenylephrine 0 (2) 0 (2) 0 (2) 0 (2) 68 f  3.5 (2) 
Note. Secretagogues were added during 15min periods to superfused lobes; 7.5min fractions were collected 
and the amount of MSH in each fraction determined with a radioimmunoassay. Average value of MSH in ihe 
three fractions before addition of secretagogue was defined as basal level and the decrease in MSH value ob- 
served for the second 7.5-min fraction of secretagogue addition was expressed as a percentage of the basal 
value. Percentage inhibition is given + SEM and the numbers in parentheses indicate the number of indepen- 
dent determinations for each concentration of secretagogue tested. 
that biosynthesis and release of pro-opio- 
melanocortin-related peptides are essen- 
tially normal, and that the ultrastructure of 
the tissue compared favorably to freshly 
dissected tissue (unpublished results). 
Biochemical (Loh and Gainer, 1977; 
Martens et al., 1982) and morphological 
studies (Jenks et al., 1977; Weatherhead 
and Whur, 1972) have shown that the cells 
of the pars intermedia of black-back- 
ground-adapted toads are extremely active 
in biosynthesis and release of melano- 
tropins. In contrast, white-background- 
adapted animals have low biosynthetic 
rates in these cells (Jenks et al., 1977) and, 
in V~‘VO, release of melanotropins is under 
tonic inhibition. During in vitro superfu- 
sion, neurointermediate lobes from black- 
background-adapted animals gave rela- 
tively stable baselines of MSR release, 
while lobes from white-background- 
adapted animals tended to give declining 
TABLE 2 
SUMMARY OF THE EFFECTS OF SPECIFIC RECEPTOR ANTAGONISTS ON SECRETAGOGUE-INDUCED INHIBTXON 
OF MSH RELEASE FROM SUPERFUSED NEUROINTERMEDLATE LOBES OF Xeaopus laevis 
Antagonists 
Propranolol Phentolamine Sulpiride 
Secretagogues (B-receptor) (or-receptor) (D-2 receptor) 
Adrenaline (LO-’ M) n.d. F nd. 
Adrenaline (lo-6M) - - + 
Noradrenaline (1O-6 M) - - + 
Isoproterenol (1O-5 w - + + 
Phenylephrine (2 x 10h5 M) n.d. + n.d. 
Note. Each secretagogue was administered during a 15min period to superfused lobes and the percentage 
inhibition of MSH secretion determined as described in Table 1. Administration of receptor antagonists (receptor 
specificity indicated in parentheses) was started several fractions before a second 15-min pulse of secretagogue 
and continued for several fractions after this pulse. inhibition of reIease by the secretagogue during this second 
pulse was compared to that obtained during the first pulse. Symbols: (+) complete or almost complete antago- 
nism of inhibitory effect of secretagogue; (2) partial antagonism of inhibitory effect of secretagogue; (-) no 
detectable antagonism of secretagogue; n.d., not determined. 
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FIG. 3. Effect of a-adrenergic receptor agonist 
phenylephrine and a-adrenergic receptor antagonist 
phentolamine on MSH secretion from superfused 
neurointermediate lobes of black-background-adapted 
Xenopus laevis. Phenylephrine (2 x 10e5 M) was 
added during two 15min periods; phentolamine ad- 
ministration was started several fractions before the 
second pulse of phenylephrine and continued for sev- 
eral fractions after this pulse, as indicated in the 
figure. Figure represents the mean of four experi- 
ments. Bars represent - SEM and basal levels of re- 
lease from the individual lobes were 1816, 3024, 2648, 
and 2008 pg MSH/fraction. 
baselines. In our opinion this latter obser- 
vation is indicative of hormone depletion 
and reflects the low biosynthetic capacity 
of the melanotropes of white-adapted an- 
imals. In lobes of black-adapted animals 
the high level of hormone production can 
apparently maintain a high rate of in vitro 
release. 
The results of our super-fusion experi- 
ments clearly show that the indolamine se- 
rotonin has no effect on the rate of MSH 
release from the pars intermedia of either 
white- or black-background adapted 
Xenopus. Immunocytochemically, we have 
found that in X. laevis, serotonergic fibers 
are restricted to the neural lobe, and no ev- 
idence for the presence of serotonin in the 
pars intermedia was found (unpublished re- 
sults). Thus it would seem unlikely that se- 
rotonin plays a direct role in the regulation 
of peptide release from the pars intermedia 
of Xenopus. In this respect, there could be 
species differences in the regulation of me- 
lanotropin release. Thornton and Gesch- 
wind (1975) found a dose-dependent potent 
stimulation of MSH release in the lizard 
Anolis carolensis. Ueda et al. (1984) and 
Kondo et al. (1983) demonstrated the pres- 
ence of serotonergic fibers in the pars in- 
termedia of Rana catesbeiana. That sero- 
tonergic innervation of the pars intermedia 
might be restricted to lower vertebrate 
species is suggested by the studies of 
Kondo and coworkers, who showed that 
the pars intermedia of the rat, hamster, and 
dog were serotonin negative. 
Electron microscopic studies have indi- 
cated the existence of cholinergic axon ves- 
icles in the pars intermedia of Rana (Nakai 
and Gorbman, 1969) and the neurotrans- 
mitter acetylcholine has been shown to 
stimulate MSH secretion (Davis and 
Hadley, 1978). Hopkins (1971), in charac- 
terizing neurons of the pars intermedia of 
X. laevi , concluded that cholinergic inner- 
vation i il absent from the intermediate lobe 
of this species. The results of our superfu- 
sion studies, showing .that acetylcholine 
has no influence on MSH secretion, are in 
agreement with Hopkins’ conclusion that 
acetylcholine has no role, at the level of the 
Xenopus pars intermedia, in regulating me- 
lanotropin release. 
The observation that both adrenaline and 
noradrenaline were very effective in in- 
ducing inhibition of MSH release in a dose- 
dependent manner suggests the involve- 
ment of an a-adrenergic receptor mecha- 
nism. This suggestion is supported by the 
fact that the cw-adrenergic receptor agonist 
phenylephrine inhibited hormone release, a 
response that could be antagonized by 
phentolamine. However, high concentra- 
tions of phenylephrine were needed and in 
antagonizing the adrenaline- and noradren- 
aline-induced inhibition of secretion, the 
dopamine D-2 receptor antagonist sulpiride 
proved to be much more potent than the (Y- 
adrenergic receptor antagonist phentol- 
amine. This indicates that, in vitro’ at least, 
adrenaline and noradrenaline inhibit MSH 
release primarily through a dopamine re- 
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FIG. 4. Effect of B-adrenergic receptor antagonist isoproterenol on MSH secretion from superfused 
neurointermediate lobes of black-background-adapted Xenopus lnevis. (a) Effect on secretion from 
lobes of black-background-adapted animals; (b) effect on secretion from lobes of white-background- 
adapted animals; (c) and (d) effects of B-adrenergic receptor antagonist propranolol and dopamine D-2 
receptor antagonist sulpiride on isoproterenol-induced inhibition of MSH release. The concentrations 
of isoproterenol and receptor antagonists used are indicated in the figures. Administration of the 
receptor antagonist was started several fractions before the second pulse of isoproterenol and con- 
tinued for several fractions after this pulse. All graphs represent the mean of at least two individual 
experiments and bars represent - SEM. Basal levels of release for individual lobes within each ex- 
periment were isoproterenol black, 2608 and 2312 pg MSH/fraction; isoproterenol white, 1424 and 948 
pg MSH/fraction; isoproterenolipropranolol, 2408and 872 pg MSHifraction; isoproterenolisulpiride, 
1600. 1128, 1868, and 1336 pg MSH/fraction. 
ceptor mechanism, similar to the situation 
reported for the rat pars intermedia (Mune- 
mura et al., 1980). In in vitro experiments 
the tissue is, of necessity, flooded with po- 
tential secretagogue. In this situation 
adrenaline or noradrenaline can inhibit 
MSH release through activation of either 
abundantly available dopamine-type re- 
ceptors (a manuscript concerning their 
characteristics is in preparation), or less 
abundant a-adrenergic receptors. If in viva, 
however, the neurotransmitter was to be 
delivered to the tissue in highly directed 
synapses between adrenergic nerve ter- 
minals and the melanotropes; then it 
cannot be excluded that an a-adrenergic 
receptor mechanism plays a role in regu- 
lating the pars intermedia function. 
With respect to possible P-adrenergic re- 
ceptor mechanisms, we have shown that 
for Xenopus, low concentrations of the l3- 
adrenergic receptor agonist isoproterenol 
have no effect on MSH release and that 
high concentrations actually inhibit release, 
The fact that this inhibition could not be 
blocked by, the P-receptor antagonist pro* 
pranolol, but was blocked by sulpiride or 
phentolamine, indicates that it does not in- 
volve activation of a P-adrenergic receptor; 
and we therefore conclude that Xenapus 
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FIG. 5. Effects of 8-bromo-adenosine 3’,5’-cyclic monophosphate (CAMP) on MSH secretion from 
super-fused neurointermediate lobes obtained from black- and white-background-adapted Xenopus 
laevis. The concentrations and times of CAMP administration are indicated in the figure. All graphs 
represent the means of at least two experiments and bars represent -SEM. Basal levels of release for 
the individual lobes within each experiment were (a) CAMP black, 264 and 280 pg MSHifraction; (b) 
CAMP white, 300 and 972 pg MSH/fraction; (c) CAMP white, 356 and 388 pg MSHifraction; (d) CAMP 
white, 1104, 1864, and 1760 pg MSH/fraction. 
melanotropes are not regulated through a 
P-adrenergic mechanism. In contrast, it has 
been demonstrated for both R. pipiens 
(Bower et al., 1974) and R. ridibunda 
(Tonon et al., 1983) that a P-receptor mech- 
anism stimulates release of MSH from the 
pars intermedia. It is interesting to note 
that with respect to the P-adrenergic re- 
ceptor, a similar discrepancy between the 
frog and Xenopus has been reported for 
the receptor profile of their erythrocytes. 
Frog erythrocytes contain a high number of 
p-adrenergic receptors, whereas the eryth- 
rocytes of Xenopus lack this type of re- 
ceptor (Cerione et al., 1983). 
P-adrenergic receptors generally activate 
the adenylate cyclase system (Cote et al., 
1980; Munemura et al., 1980). The lack of 
this receptor on MSH cells of X. laevis 
raises questions concerning the involve- 
ment of cyclic-AMP as an intracellular 
factor for stimulation of hormone release. 
In both our present experiments and those 
reported earlier (Jenks et al., 1977), we 
found a clear stimulation of MSH release, 
in contrast to Loh et al. (1981) who con- 
clude from their results that cyclic-AMP in- 
hibits release of MSH. In the present in- 
vestigation the superfusion system has al- 
lowed us to follow the time course of 
cyclic-AMP-induced stimulation. These 
studies have revealed that a pulse of S-Br- 
cyclic-AMP is so effective in stimulating 
the secretory process, that in many cases 
the lobes became almost depleted of MSH 
and thus could no longer maintain release 
and were hardly sensitive to subsequent REFERENCES 
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cyte-stimulating hormone (MSH) secretion. 
adapted animals were already elevated, re- Neuroendocrinology 26, 271-282. 
flecting the physiological state of the an- Dierst-Davis, K., Ralph, C. L., and Pechersky, J. L. 
imals prior to conducting the experiments. (1966). Effects of pharmacological agents on the 
In that Xevlopus lacks a P-adrenergic re- 
hypothalamus of Rana pipiens in relation to the 
ceptor, still to be resolved are questions 
control of skin melanophores. Gen. Comp. Endo- 
crinol. 6, 409-419. 
concerning which receptor systems might Hadley, M. E., Hruby, V. .I., Bower, A. (1976).. Cel- 
be involved in activation of the adenylate lular mechanisms controlling melanophore stimu- 
cyclase system in the melanotropes of this lating hormone (MSH) release. Gen. COIMP. En- 
species. In recent experiments we have docrinol. 26, 24-35. 
found that both the neuropeptides thyro- 
Hogben, L., and Slome, D. (1931). The pigmentary 
effector system. VI. The dual character of endo- 
tropin-releasing hormone and cortico- crine coordination in amphibian color change. 
tropin-releasing hormone show a similar Proc. R. Sot. London Ser. B 108, 10-53. 
phenomenon as that displayed by cyclic- Hopkins, C. R. (1971). Localization of adrenergic 
AMP, namely, that they stimulate release 
fibers in the amphibian pars intermedia by elec- 
from lobes of white-adapted but not black- 
tron microscope autoradiography and their selec- 
tive removal by 6-hydroxydopamine. Gen. COMIC. 
adapted animals (manuscript in prepara- Endocrinol. 16, 112- 120. 
tion). We are investigating whether one of Jackson, S., and Lowry, P. J. (1983). Secretion odpro- 
these neuropeptides could be an MISH re- opiocortin peptides from isolated perfused rat 
lease stimulating factor in X. laevis. 
pars intermedia cells. Neuroendocrinalogy 37, 
248-257. 
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